7 days later, the transferred cells were in the tumor and had downregulated TCF-1, CD62L, increased expression of PD-1 and upregulated GZMB and TIM-3 demonstrating an ability to differentiate into an effector-like subset (Fig. 6g, h). The gene discussed is TCF7; the disease is neoplasm.